The complex language and technical nature of the Australian Evidence-Based Clinical Practice Guideline for ADHD may present challenges for those without a clinical background to understand fully.
To address this, a Consumer Companion was developed to make the information in the Guideline more accessible for individuals with ADHD, their families, and other stakeholders.
The Consumer Companion aims to provide age-related recommendations on treatment options and outlines how these options should be tailored to the specific needs and preferences of people living with ADHD.
Written by Louise Brown, a person with lived experience and AADPA Board Director, the Consumer Companion has been reviewed by members of the original Guideline development group as well as AADPA President, Prof. David Coghill and Guideline Lead, Prof. Mark Bellgrove.
